Blue Owl Capital Holdings’s Roivant Sciences ROIV Stock Holding History

Blue Owl Capital Holdings’s Portfolio ROIV Stock Details ROIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-263,249	Closed	-$5.71M	–	89
2025 Q4	$5.71M	Sell	263,249 -725,000	-73%	-$14.3M	1.76%	18
2025 Q3	$15M	Buy	+988,249	New	+$12.2M	4.64%	7
2025 Q2	–	Sell	-39,003	Closed	-$394K	–	78
2025 Q1	$394K	Hold	39,003	–	–	0.13%	39
2024 Q4	$461K	Hold	39,003	–	–	0.11%	41
2024 Q3	$450K	Buy	+39,003	New	+$444K	0.09%	50

Other funds holding ROIV

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Blue Owl Capital Holdings's ROIV Position: Q1 2026 in Review

Blue Owl Capital Holdings sold out of Roivant Sciences (ROIV) in Q1 2026, closing a stake of 263,249 shares — an estimated $5.71M sold.

Blue Owl Capital Holdings first reported a position in ROIV in Q3 2024 and held it in 5 quarters. The position peaked at $15M in Q3 2025. 444 funds tracked by Wall St. Rank hold ROIV as of Q1 2026.

Blue Owl Capital Holdings reported no remaining Roivant Sciences position as of Q1 2026 after selling out during the quarter.
Blue Owl Capital Holdings sold 263,249 Roivant Sciences shares in Q1 2026, an estimated $5.71M.
Blue Owl Capital Holdings first reported a position in Roivant Sciences in Q3 2024 and held it in 5 quarters.
Blue Owl Capital Holdings's Roivant Sciences position peaked at $15M in Q3 2025.
444 funds tracked by Wall St. Rank held Roivant Sciences as of Q1 2026.

Based on Blue Owl Capital Holdings's 13F filing for Q1 2026, filed 14 May 2026.